Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Oluwatoyin A. Adeleke"'
Publikováno v:
Pharmaceutics, Vol 16, Iss 6, p 712 (2024)
Paediatric infectious diseases contribute significantly to global health challenges. Conventional therapeutic interventions are not always suitable for children, as they are regularly accompanied with long-standing disadvantages that negatively impac
Externí odkaz:
https://doaj.org/article/83a0737c5f9d4141a310a146b1e87ba4
Publikováno v:
Pharmaceutics, Vol 15, Iss 3, p 986 (2023)
Chronic wounds are one of the secondary health complications that develop in individuals who have poorly managed diabetes mellitus. This is often associated with delays in the wound healing process, resulting from long-term uncontrolled blood glucose
Externí odkaz:
https://doaj.org/article/d35bcce6c73d4e1b9321ce2ee99267c2
Publikováno v:
Pharmaceutics, Vol 15, Iss 1, p 64 (2022)
The scarcity of age-appropriate pharmaceutical formulations is one of the major challenges impeding successful management of tuberculosis (TB) prevalence in minors. To this end, we designed and assessed the quality of a multiparticulate reconstitutab
Externí odkaz:
https://doaj.org/article/4877322091fa48aca6f6b5e50f315703
Autor:
Lehlogonolo N. F. Maphalle, Bozena B. Michniak-Kohn, Modupe O. Ogunrombi, Oluwatoyin A. Adeleke
Publikováno v:
Children, Vol 9, Iss 8, p 1120 (2022)
Managing pediatric tuberculosis (TB) remains a public health problem requiring urgent and long-lasting solutions as TB is one of the top ten causes of ill health and death in children as well as adolescents universally. Minors are particularly suscep
Externí odkaz:
https://doaj.org/article/8dfff792a1f847b59d56839a5a5bf678
Autor:
Oluwatoyin A. Adeleke
Publikováno v:
International Journal of Pharmaceutics: X, Vol 1, Iss , Pp - (2019)
Premium ethylcellulose polymers are hydrophobic cellulose ether based biomaterials widely employed as biocompatible templates for the design of novel drug delivery systems. They are classified as United States Food and Drug Administration Generally-R
Externí odkaz:
https://doaj.org/article/4622f08c3d1f4f93b8d33298f0d5ec90
Publikováno v:
Pharmaceutics, Vol 12, Iss 3, p 286 (2020)
Tuberculosis (TB) is a major cause of childhood death. Despite the startling statistics, it is neglected globally as evidenced by treatment and clinical care schemes, mostly extrapolated from studies in adults. The objective of this study was to form
Externí odkaz:
https://doaj.org/article/24e015a504304f7a97fd050cb7b07d51
Autor:
Emma A. Kean, Oluwatoyin A. Adeleke
Publikováno v:
European Journal of Pharmaceutical Sciences. 182:106377
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b915f609eca32752868d2482158e93d
https://doi.org/10.1016/j.ejps.2023.106377
https://doi.org/10.1016/j.ejps.2023.106377
Autor:
Oluwatoyin A. Adeleke
Publikováno v:
SN Applied Sciences. 2
An erodible polyamide 6,10 based drug carrier was fabricated for continuous, extended release of a model hydrophilic drug, amitriptyline hydrochloride. The developed polyamide-based drug loaded compact disc was stable, semi-crystalline, mechanically
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee8422860c6754da71748ef1f1a757f0
https://doi.org/10.1007/s42452-020-03954-x
https://doi.org/10.1007/s42452-020-03954-x
Publikováno v:
International Journal of Molecular Sciences
Volume 21
Issue 16
International Journal of Molecular Sciences, Vol 21, Iss 5714, p 5714 (2020)
Volume 21
Issue 16
International Journal of Molecular Sciences, Vol 21, Iss 5714, p 5714 (2020)
The severity of tuberculosis (TB) in children is considered a global crisis compounded by the scarcity of pharmaceutical formulations suitable for pediatric use. The purpose of this study was to optimally develop and evaluate a pyrazinamide containin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bea49b03520bf5ff8c8a83aa63538123
https://pubmed.ncbi.nlm.nih.gov/32784947
https://pubmed.ncbi.nlm.nih.gov/32784947
Publikováno v:
Pharmaceutics
Volume 12
Issue 3
Pharmaceutics, Vol 12, Iss 3, p 286 (2020)
Volume 12
Issue 3
Pharmaceutics, Vol 12, Iss 3, p 286 (2020)
Tuberculosis (TB) is a major cause of childhood death. Despite the startling statistics, it is neglected globally as evidenced by treatment and clinical care schemes, mostly extrapolated from studies in adults. The objective of this study was to form
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7498ac7767e8977530c1032ce96ead19
http://europepmc.org/articles/PMC7151029
http://europepmc.org/articles/PMC7151029